Congress Reauthorizes Rare Pediatric Disease PRV Program: A Major Win for 30 million Americans

U.S. Congress delivered a major victory for the rare disease community with the five-year reauthorization of the Rare Pediatric Disease Priority Review Voucher (PRV) Program alongside increased federal research funding and several patient-centered healthcare reforms.